CN102028901B - Traditional Chinese medicine for treating knee joint hypertrophic synovitis - Google Patents
Traditional Chinese medicine for treating knee joint hypertrophic synovitis Download PDFInfo
- Publication number
- CN102028901B CN102028901B CN2010105792441A CN201010579244A CN102028901B CN 102028901 B CN102028901 B CN 102028901B CN 2010105792441 A CN2010105792441 A CN 2010105792441A CN 201010579244 A CN201010579244 A CN 201010579244A CN 102028901 B CN102028901 B CN 102028901B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- rhizoma atractylodis
- synovitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention relates to a traditional Chinese medicine for treating knee joint hypertrophic synovitis, belonging to the technical field of osteological and traumatological treatment. The traditional Chinese medicine is characterized by being prepared from the following traditional Chinese medicinal materials in parts by weight: 10-15 parts of rhizoma atractylodis, 10-15 parts of rhizoma atractylodis macrocephalae, 25-35 parts of honeysuckle, 20-30 parts of pachyma cocos peel, 25-35 parts of Semen Coicis, 10-20 parts of Chinese teasel root, 15-25 parts of radix cyathulae, 25-35 parts of erythrina bark, 10-15 parts of sargentg loryvine, 8-14 parts of eucommia bark, 10-15 parts of Morinda officinalis and 10-15 parts of Radix Gentianae Macrophyllae. In accordance with the pathological principles of neck/knee joint hypertrophic synovitis symptoms and the causes of the knee joint hypertrophic synovitis symptoms, the invention can purify and prepare the medicinal materials into oral liquids, or tablets, or powder, or capsules or pills based on a pure traditional Chinese medicine prescription. When being taken periodically in course of treatment, the traditional Chinese medicine can effectively treat knee joint hypertrophic synovitis symptoms and achieve an ideal effect.
Description
Technical field:
The present invention relates to orthopedics department treatment field, relate in particular to a kind of technical field of Chinese medicines of treating knee hyperplasia property synovitis.
Background technology:
Knee hyperplasia property synovitis is the common a kind of diseases of person in middle and old age, brings stress, health misery and financial burden for countless patients.
At present, the medicine of treatment knee hyperplasia property synovitis has Chinese medicine, Western medicine, but curative effect does not all make patient satisfaction.According to pathogenic factor, the pathological change of knee hyperplasia property synovitis, warp is investigated in many ways, textual criticism, scientific validation are learnt repeatedly, cause the reason of knee hyperplasia property synovitis to mainly contain following several kinds of situation: the one, and damp and hot resistance network, poor blood circulation; The 2nd, receive external force pressure, cause the variation of health skeleton; The 3rd, work and living environment cause knee hyperplasia property synovitis.
Summary of the invention:
The technical problem that the present invention will solve is to overcome the deficiency that prior art exists; And a kind of Chinese patent medicine of treating knee hyperplasia property synovitis is provided; Can not cure the reality of knee hyperplasia property synovitis to existing medicine at all; The present invention adopts traditional pure Chinese medicine, supplies the patient to take with oral liquid, powder, tablet, capsular form, can effectively treat dissimilar knee hyperplasia property synovitis diseases.
The present invention takes to implement following technical scheme for solving the problems of the technologies described above: a kind of Chinese medicine of treating knee hyperplasia property synovitis is characterized in that: it is that Chinese crude drug following composition by weight is prepared from: 10 1 15 parts of Rhizoma Atractylodis; 10 1 15 parts of the Rhizoma Atractylodis Macrocephalaes, 25 1 35 parts of Flos Loniceraes, 20 1 30 parts of volt Siberian cocklebur skins; 25 1 35 parts of Semen Coiciss, 10 1 20 parts of Radix Dipsacis, 15 1 25 parts of Radix Cyathulaes; 25 1 35 parts of Cortex erythrinaes, 10 1 15 parts of Caulis Sargentodoxae, 8 one 14 parts of Cortex Eucommiaes; 10 1 15 parts of Radix Morindae Officinaliss, 10 1 15 parts of RADIX GENTIANAE MACROPHYLLAEs.
The Chinese medicine of above-mentioned treatment knee hyperplasia property synovitis, it is to be prepared from the following preferably Chinese crude drug of composition by weight: 11 1 14 parts of Rhizoma Atractylodis, 11 1 14 parts of the Rhizoma Atractylodis Macrocephalaes, 26 1 34 parts of Flos Loniceraes; 21 1 29 parts of volt Siberian cocklebur skins, 26 1 34 parts of Semen Coiciss, 11 1 19 parts of Radix Dipsacis; 16 1 24 parts of Radix Cyathulaes, 26 1 34 parts of Cortex erythrinaes, 11 1 14 parts of Caulis Sargentodoxae; 9 one 13 parts of Cortex Eucommiaes, 11 1 14 parts of Radix Morindae Officinaliss, 11 1 14 parts of RADIX GENTIANAE MACROPHYLLAEs.
The Chinese medicine of above-mentioned treatment knee hyperplasia property synovitis, it is that Chinese crude drug the composition by weight of following the best is prepared from: 13 parts of Rhizoma Atractylodis, 13 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Flos Loniceraes; 25 parts of volt Siberian cocklebur skins, 30 parts of Semen Coiciss, 15 parts of Radix Dipsacis; 20 parts of Radix Cyathulaes, 30 parts of Cortex erythrinaes, 13 parts of Caulis Sargentodoxae; 10 parts of Cortex Eucommiaes, 13 parts of Radix Morindae Officinaliss, 13 parts of RADIX GENTIANAE MACROPHYLLAEs.
Because the present invention is a Chinese medicine preparation, the active ingredient of preparation all is a Chinese herbal medicine, and the component compatibility is reasonable.It is got through passages through which vital energy circulates, repairs affected bone, promotes telangiectasis, improves immune function of human body to regulate the blood flow circulation, thereby reaches the purpose of treatment knee hyperplasia property inflammation.
Rhizoma Atractylodis: acrid in the mouth, main loosing, warm in nature and dry, go into spleen, stomach warp.Effect cures mainly, and Rhizoma Atractylodis have drying damp and strengthening spleen, the effect of wind-damp dispelling.Cure mainly retention of dampness in middle-JIAO, anemofrigid-damp arthralgia, the foot swelling and pain in knee, flaccidity is soft unable, nyctalopia nyctalopia, the peace that can be good for the stomach spleen.
The Rhizoma Atractylodis Macrocephalae: bitter but sweet flavor, warm in nature, nontoxic.Go into spleen, stomach warp.The effect of the Rhizoma Atractylodis Macrocephalae, spleen reinforcing, stomach reinforcing, dampness and in, antiabortive.Control deficient QI of the spleen and stomach, anorexia, the asthenia weak breath, deficiency-distension is had loose bowels, phlegm retention, edema, jaundice, arthralgia chiefly caused by damp pathogen, dysuria, dizziness, spontaneous perspiration, nausea is uneasy.
Flos Lonicerae: sweet in the mouth, cold in nature.Return lung, the heart, stomach warp.The function of Flos Lonicerae, heat-clearing and toxic substances removing, wind-heat dissipating.
Volt Siberian cocklebur skin: sweet in the mouth, light, property is flat.Return liver, stomach warp.Function cures mainly, dehumidifying, detoxifcation, easing joint movement.Be used for damp and hot stranguria with turbid discharge, leukorrhagia, carbuncle, the limbs contracture due to the scrofula, scabies, syphilis and mercurialism, bones and muscles pain.
Semen Coicis: slightly sweet flavor, cool in nature.Go into spleen, lung, kidney channel.The effect of Semen Coicis, spleen invigorating, tonifying the lung, heat clearing away, dampness removing.Control and have loose bowels, arthralgia chiefly caused by damp pathogen, the contracture of muscle arteries and veins, joint stuffiness, edema, beriberi, consumptive lung disease, lung abscess, acute appendicitis, stranguria with turbid discharge, leucorrhea.
Caulis Spatholobi: warm in nature, bitter in the mouth, return liver, kidney channel.The function promoting the circulation of blood of enriching blood, latus rectum, active cures mainly diseases such as blood deficiency, rheumatic arthralgia, muscles and bones numbness.
Radix Dipsaci: bitter in the mouth is hot, and slightly warm in nature is nontoxic.Go into liver, kidney channel.Radix Dipsaci is the conventional Chinese medicine material, in Shennong's Herbal, classifies as top gradely, has invigorating the liver and kidney, bone and muscle strengthening, continuous folding and hinders, ends metrorrhagia, effect such as antiabortive.
Radix Cyathulae: property is flat, and sweet in the mouth, little hardship are nontoxic.Go into liver, kidney two warps.The effect of Radix Cyathulae is dispeled the wind, and dampness removing stimulates the menstrual flow, and invigorates blood circulation.The dispelling the wind and dampness pathogens lumbocrural pain, foot flaccidity clonic spasm of the muscle, stranguria with blood, hematuria, women's amenorrhea ， mass in the abdomen, arthralgia, injury from falling down.
Cortex erythrinae: performance characteristics, the property of medicine of wind-damp-dispelling and cold-dissipating medicinal and wind-damp dispelling bone and muscle strengthening medicine is warm partially in this type medicine, and the property of medicine of wind-damp-dispelling and heat-clearing medicinal is relatively cold and cool.Flavor is how hot, bitter.Its suffering can be dispeled the wind, bitter ability dampness, and temperature ability cold expelling, trembling with fear can heat clearing away.Suffering from the joint muscles and bones of arthralgia pain, is by liver, kidney two dirty leading, so return this two warp.Wind-damp dispelling, the meridian dredging: be used for the rheumatism arthromyodynia, lumbocrural pain, numb limbs and tense tendons, the contracture of muscle arteries and veins.
RADIX GENTIANAE MACROPHYLLAE: bitter in the mouth, suffering, cold nature.Return stomach, liver, gallbladder meridian.The effect of RADIX GENTIANAE MACROPHYLLAE, wind-damp dispelling, stopping numbness pain, reducing the asthenic fever, clearing away damp-heat.Cure mainly rheumatic arthralgia, the contracture of muscle arteries and veins, hands and feet caused by paralysis, osteopyrexia and fever, jaundice due to damp-heat.
Cortex Eucommiae: acrid in the mouth, warm in nature, nontoxic.Go into liver, kidney channel.Invigorating the liver and kidney, bone and muscle strengthening, antiabortive.Cure mainly the spinal column ache, foot and knee flaccidity, dribbling urination, uncontrolled urination is itched, and vaginal bleeding during pregnancy is desired to fall, hypertension.Liver and kidney tonifying, the nourishing muscle and tendon bone goes to the joint wet excessive.
Radix Morindae Officinalis: have another name called three MANCAOs, bitter in the mouth, Xin Gan, warm in nature, nontoxic.Go into liver, kidney channel.The effect of Radix Morindae Officinalis, kidney-replenishing, strengthening bone and muscle, wind-damp dispelling.Control sexual impotence, few abdomen cold type of pain, incontinence of urine, deficiency-cold of uterus, anemofrigid-damp arthralgia, soreness of waist and knee joint.
More than each component phase
coordinative role.Make this medical instrument that wind-damp dispelling, the meridian dredging, arresting convulsion, pain relieving arranged, improve effects such as blood circulation.This drug regimen is prepared into oral medicine take after; Through each cell tissue delivery of oxygen of blood and various nutrient, remove the blood flow path through obstacle, adjusting blood circulation, active cell tissue and function of human body; Improve body immunity, reach the purpose of treatment knee hyperplasia property synovitis; Behind this drug administration, treatment knee hyperplasia property synovitis disease is had significant curative effect, cure rate reaches more than 90%.
The treatment standard:
Typical case's knee hyperplasia property synovitis treatment standard: be clearly better in one month; Transfer numbness to by pain, obvious effective rate reaches more than 85%, along with increase the course of treatment; Pain, feeling of numbness disappear after three months; Knee hyperplasia property synovitis is controlled, and patient progressively gets well, and total cure rate reaches more than 90%.
Treatment course of treatment: 10 days is a course of treatment, nine courses of treatment of continuous use.
Therapeutic effect: with 2,006 one 2008 be example, accept 24 of knee hyperplasia property synovitis patients in 3 years altogether, after one month (three courses of treatment); Transfer 15 numb people to by pain; 15 people that heal three months (nine courses of treatment) entirely, 5 people of healing basically entirely, only surplus 4 people continue to receive treatment.
Typical case's introduction of falling ill:
1, the big man of Jiang De 53 years old, lives the Fushan District Dong Tingzhen of Yantai City.The peasant, knee hyperplasia property synovitis pain influences normally work unbearably, uses this pharmaceutical formulation (taking orally) after the course of treatment; The knee joint numbness occurs and swell, after three courses of treatment, gonalgia transference cure; After nine courses of treatment, gonitis disappears, and physical recovery is normal.
2, in moral water man, 58 years old, live Xiao Guan town, Wendeng City, the peasant; Knee hyperplasia property synovitis pain can not normally be worked unbearably, uses this pharmaceutical formulation (taking orally) after the course of treatment; The cervical vertebra numbness occurs and swell, after three courses of treatment, gonalgia transference cure; After nine courses of treatment, gonitis disappears, and physical recovery is normal.
3, in the Cuiping woman, 56 years old, live Mi Shan town, Wendeng City.The peasant, knee hyperplasia property synovitis pain can not normally be worked unbearably, uses this pharmaceutical formulation (taking orally) after the course of treatment; The numb heating of knee joint appears, after three courses of treatment, and gonalgia transference cure; After nine courses of treatment, gonitis disappears, and physical recovery is normal.
The specific embodiment:
Embodiment 1:
With decoction treatment knee hyperplasia property synovitis disease.10 parts of Rhizoma Atractylodis, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 25 parts of Flos Loniceraes, 20 parts of volt Siberian cocklebur skins, 25 parts of Semen Coiciss, 10 parts of Radix Dipsacis, 15 parts of Radix Cyathulaes, 25 parts of Cortex erythrinaes, 10 parts of Caulis Sargentodoxae, 8 parts of Cortex Eucommiaes, 10 parts of Radix Morindae Officinaliss, 10 parts of RADIX GENTIANAE MACROPHYLLAEs.Be prepared into oral liquid for oral administration through extracting active ingredient.Take by the course of treatment, per 10 days is a course of treatment, serve on 9 courses of treatment, can effectively treat knee hyperplasia property synovitis disease, reaches ideal effect.
Embodiment 2:
With pill treatment knee hyperplasia property synovitis disease.15 parts of Rhizoma Atractylodis, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 35 parts of Flos Loniceraes, 30 parts of volt Siberian cocklebur skins, 35 parts of Semen Coiciss, 20 parts of Radix Dipsacis, 25 parts of Radix Cyathulaes, 35 parts of Cortex erythrinaes, 15 parts of Caulis Sargentodoxae, 14 parts of Cortex Eucommiaes, 15 parts of Radix Morindae Officinaliss, 15 parts of RADIX GENTIANAE MACROPHYLLAEs.Above component oven dry is ground, add Mel, be prepared into ball, take by the course of treatment, per 10 days is a course of treatment, serve on 9 courses of treatment, can effectively treat knee hyperplasia property synovitis disease, reaches ideal effect.
Embodiment 3:
With powder treatment knee hyperplasia property synovitis disease.11 parts of Rhizoma Atractylodis, 11 parts of the Rhizoma Atractylodis Macrocephalaes, 26 parts of Flos Loniceraes, 21 parts of volt Siberian cocklebur skins, 26 parts of Semen Coiciss, 11 parts of Radix Dipsacis, 16 parts of Radix Cyathulaes, 26 parts of Cortex erythrinaes, 11 parts of Caulis Sargentodoxae, 9 parts of Cortex Eucommiaes, 11 parts of Radix Morindae Officinaliss, 11 parts of RADIX GENTIANAE MACROPHYLLAEs.With the processing of said medicine component, deduction, be prepared into powder for oral administration or tablet or capsule by modern production technology.Take by the course of treatment, per 10 days is a course of treatment, serve on 9 courses of treatment, can effectively treat knee hyperplasia property synovitis disease, reaches ideal effect.
Embodiment 4:
With capsule dress powder oral medicine treatment knee hyperplasia property synovitis disease.14 parts of Rhizoma Atractylodis, 14 parts of the Rhizoma Atractylodis Macrocephalaes, 34 parts of Flos Loniceraes, 29 parts of volt Siberian cocklebur skins, 34 parts of Semen Coiciss, 19 parts of Radix Dipsacis, 24 parts of Radix Cyathulaes, 34 parts of Cortex erythrinaes, 14 parts of Caulis Sargentodoxae, 13 parts of Cortex Eucommiaes, 14 parts of Radix Morindae Officinaliss, 14 parts of RADIX GENTIANAE MACROPHYLLAEs.As above Chinese medicine is produced oral medicine according to the production technology of capsule dress powder, take by the course of treatment, per 10 days is a course of treatment, serve on 9 courses of treatment, can effectively treat knee hyperplasia property synovitis disease, reaches ideal effect.
Embodiment 5:
With tablet oral medication knee hyperplasia property synovitis disease.13 parts of Rhizoma Atractylodis, 13 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Flos Loniceraes, 25 parts of volt Siberian cocklebur skins, 30 parts of Semen Coiciss, 15 parts of Radix Dipsacis, 20 parts of Radix Cyathulaes, 30 parts of Cortex erythrinaes, 13 parts of Caulis Sargentodoxae, 10 parts of Cortex Eucommiaes, 13 parts of Radix Morindae Officinaliss, 13 parts of RADIX GENTIANAE MACROPHYLLAEs.As above Chinese medicine is produced the tablet oral medicine according to the conventional production technology of tablet oral medicine, and per 10 days is a course of treatment, serve on 9 courses of treatment, can effectively treat knee hyperplasia property synovitis disease, reaches ideal effect.
Claims (4)
1. Chinese medicine of treating knee hyperplasia property synovitis is characterized in that: it is that Chinese crude drug following composition by weight is prepared from: 10 1 15 parts of Rhizoma Atractylodis, 10 1 15 parts of the Rhizoma Atractylodis Macrocephalaes, 25 1 35 parts of Flos Loniceraes; 20 1 30 parts of volt Siberian cocklebur skins, 25 1 35 parts of Semen Coiciss, 10 1 20 parts of Radix Dipsacis; 15 1 25 parts of Radix Cyathulaes, 25 1 35 parts of Cortex erythrinaes, 10 1 15 parts of Caulis Sargentodoxae; 8 one 14 parts of Cortex Eucommiaes, 10 1 15 parts of Radix Morindae Officinaliss, 10 1 15 parts of RADIX GENTIANAE MACROPHYLLAEs.
2. the Chinese medicine of treatment knee hyperplasia property synovitis according to claim 1 is characterized in that: it is that Chinese crude drug following composition by weight is prepared from: 11 1 14 parts of Rhizoma Atractylodis, 11 1 14 parts of the Rhizoma Atractylodis Macrocephalaes, 26 1 34 parts of Flos Loniceraes; 21 1 29 parts of volt Siberian cocklebur skins, 26 1 34 parts of Semen Coiciss, 11 1 19 parts of Radix Dipsacis; 16 1 24 parts of Radix Cyathulaes, 26 1 34 parts of Cortex erythrinaes, 11 1 14 parts of Caulis Sargentodoxae; 9 one 13 parts of Cortex Eucommiaes, 11 1 14 parts of Radix Morindae Officinaliss, 11 1 14 parts of RADIX GENTIANAE MACROPHYLLAEs.
3. the Chinese medicine of treatment knee hyperplasia property synovitis according to claim 1 is characterized in that: it is that Chinese crude drug following composition by weight is prepared from: 13 parts of Rhizoma Atractylodis, 13 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Flos Loniceraes; 25 parts of volt Siberian cocklebur skins, 30 parts of Semen Coiciss, 15 parts of Radix Dipsacis; 20 parts of Radix Cyathulaes, 30 parts of Cortex erythrinaes, 13 parts of Caulis Sargentodoxae; 10 parts of Cortex Eucommiaes, 13 parts of Radix Morindae Officinaliss, 13 parts of RADIX GENTIANAE MACROPHYLLAEs.
4. according to the Chinese medicine of claim 1 or the described treatment knee hyperplasia property of 2 or 3 arbitrary claim synovitis, it is characterized in that said Chinese medicine is prepared into pill, powder or capsule according to conventional technology of preparing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105792441A CN102028901B (en) | 2010-11-26 | 2010-11-26 | Traditional Chinese medicine for treating knee joint hypertrophic synovitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105792441A CN102028901B (en) | 2010-11-26 | 2010-11-26 | Traditional Chinese medicine for treating knee joint hypertrophic synovitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102028901A CN102028901A (en) | 2011-04-27 |
| CN102028901B true CN102028901B (en) | 2012-03-28 |
Family
ID=43882713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105792441A Expired - Fee Related CN102028901B (en) | 2010-11-26 | 2010-11-26 | Traditional Chinese medicine for treating knee joint hypertrophic synovitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102028901B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104367892A (en) * | 2014-11-18 | 2015-02-25 | 王刚 | Orally-taken and externally-applied traditional Chinese medicine composition for treating knee joint synovitis |
| CN105497744A (en) * | 2014-11-25 | 2016-04-20 | 彭建 | Traditional Chinese medicine for curing pigmented villonodular synovitis |
| CN105412890A (en) * | 2015-12-24 | 2016-03-23 | 孙建 | Traditional Chinese medicinal fumigating and washing solution for treating gonarthromeningitis, and preparation method thereof |
| CN112451596A (en) * | 2019-09-07 | 2021-03-09 | 王旭君 | Ointment for treating gonarthromeningitis by using negundo chastetree fruit and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101357172A (en) * | 2007-07-31 | 2009-02-04 | 金昌辉 | External traditional Chinese medicine for treating hyperosteogeny, urgent lumbar sprain, joint bursitis |
| CN101757507A (en) * | 2008-12-24 | 2010-06-30 | 崔品三 | Traditional Chinese medicine for treating gonarthromeningitis |
| CN101829311A (en) * | 2010-05-18 | 2010-09-15 | 山西省屯留县科技情报服务中心 | Medicament for treating gonarthromeningitis and preparation method thereof |
-
2010
- 2010-11-26 CN CN2010105792441A patent/CN102028901B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101357172A (en) * | 2007-07-31 | 2009-02-04 | 金昌辉 | External traditional Chinese medicine for treating hyperosteogeny, urgent lumbar sprain, joint bursitis |
| CN101757507A (en) * | 2008-12-24 | 2010-06-30 | 崔品三 | Traditional Chinese medicine for treating gonarthromeningitis |
| CN101829311A (en) * | 2010-05-18 | 2010-09-15 | 山西省屯留县科技情报服务中心 | Medicament for treating gonarthromeningitis and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102028901A (en) | 2011-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103520654B (en) | A kind of Chinese medicine composition being used for the treatment of knee osteoarthritis and preparation method thereof | |
| CN100551422C (en) | A kind of endo-medicine for the treatment of intervertebral disk hernia | |
| CN103585378A (en) | A Chinese medicinal composition for treating female infertility, and its preparation method | |
| CN100571736C (en) | A kind of Chinese medicine preparation for the treatment of habitual abortion | |
| CN103705751B (en) | Chinese medicine composition being used for the treatment of lumbago due to pathogenic wind-dampness and preparation method thereof | |
| CN101961458B (en) | Oral medicament for treating osteonecrosis of femoral head | |
| CN105362650A (en) | Pharmaceutical composition for treating constipation and application method thereof | |
| CN102028901B (en) | Traditional Chinese medicine for treating knee joint hypertrophic synovitis | |
| CN102366541A (en) | Traditional Chinese medicine composition for treatment of diabetes | |
| CN102205056B (en) | Medicinal liquor for treating senile lumbocrural arthralgia | |
| CN103599404A (en) | Traditional Chinese medicinal decoction for treating cervical spondylosis | |
| CN101036706B (en) | Wine for promoting blood circulation, removing blood stasis and eliminating rheumatism | |
| CN102018821B (en) | Chinese medicament for treating hypertrophic rachitis | |
| CN102048863A (en) | Traditional Chinese medicine for treating lumbar hyperosteogeny | |
| CN102579672A (en) | Medicament for treating bone hyperplasia and lumbar disc herniation | |
| CN102058808A (en) | Traditional Chinese medicament for treating rheumatic arthritis | |
| CN102028768B (en) | Traditional Chinese medicament for treating lumbar canal stenosis | |
| CN102441131A (en) | Chinese medicinal composition for treating traumatic injury | |
| CN101040986B (en) | Chinese traditional medicine compound took orally for treating cervical spondylotic radiculopathy | |
| CN103356797A (en) | Chinese medicine composition for treating kidney stone | |
| CN104161805A (en) | Traditional Chinese medicine for treating femoral head necrosis, and preparation method thereof | |
| CN102028887B (en) | Traditional Chinese medicine for treating hyperplasia of cervical vertebra | |
| CN102018792B (en) | Traditional Chinese medicine for treating ankylosing spondylitis | |
| CN100460000C (en) | Preparation of Chinese traditional medicine for eliminating damp and promoting blood circulation to stop pain and preparation method | |
| CN103372187A (en) | Medicine for treating urticaria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120328 Termination date: 20141126 |
|
| EXPY | Termination of patent right or utility model |